(Q44101569)

29 November 2017

Clinically significant drug interaction between basiliximab and tacrolimus in renal transplant recipients (English)

1 reference

29 November 2017

N M Sifontis

1

1 reference

29 November 2017

E Benedetti

series ordinal

2

1 reference

29 November 2017

E M Vasquez

series ordinal

3

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Transplantation Proceedings

29 November 2017

1 reference

29 November 2017

34

1 reference

29 November 2017

5

1 reference

29 November 2017

1730-1732

1 reference

Important interactions of drugs with immunosuppressive agents used in transplant recipients

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903000-2

7 January 2021

Drug interactions in transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903000-2

7 January 2021

Interleukin-2 receptor antibody-induced alterations of ciclosporin dose requirements in paediatric transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903000-2

7 January 2021

Decrease in hepatic cytochrome P450 after interleukin-2 immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903000-2

7 January 2021

Functional interleukin-2 receptors on intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903000-2

7 January 2021

The interleukin-2 receptor down-regulates the expression of cytochrome P450 in cultured rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903000-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903000-2

1 reference

7 January 2021

10.1016/S0041-1345(02)03000-2

Identifiers

DOI

1 reference

29 November 2017

1 reference